首页> 美国卫生研究院文献>other >Endo-Lysosomal Dysfunction in Human Proximal Tubular Epithelial Cells Deficient for Lysosomal Cystine Transporter Cystinosin
【2h】

Endo-Lysosomal Dysfunction in Human Proximal Tubular Epithelial Cells Deficient for Lysosomal Cystine Transporter Cystinosin

机译:人近端肾小管上皮细胞内溶酶体功能障碍的溶酶体胱氨酸转运蛋白Cystinosin不足。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Nephropathic cystinosis is a lysosomal storage disorder caused by mutations in the CTNS gene encoding cystine transporter cystinosin that results in accumulation of amino acid cystine in the lysosomes throughout the body and especially affects kidneys. Early manifestations of the disease include renal Fanconi syndrome, a generalized proximal tubular dysfunction. Current therapy of cystinosis is based on cystine-lowering drug cysteamine that postpones the disease progression but offers no cure for the Fanconi syndrome. We studied the mechanisms of impaired reabsorption in human proximal tubular epithelial cells (PTEC) deficient for cystinosin and investigated the endo-lysosomal compartments of cystinosin-deficient PTEC by means of light and electron microscopy. We demonstrate that cystinosin-deficient cells had abnormal shape and distribution of the endo-lysosomal compartments and impaired endocytosis, with decreased surface expression of multiligand receptors and delayed lysosomal cargo processing. Treatment with cysteamine improved surface expression and lysosomal cargo processing but did not lead to a complete restoration and had no effect on the abnormal morphology of endo-lysosomal compartments. The obtained results improve our understanding of the mechanism of proximal tubular dysfunction in cystinosis and indicate that impaired protein reabsorption can, at least partially, be explained by abnormal trafficking of endosomal vesicles.
机译:肾病性胱氨酸病是一种溶酶体贮积病,是由编码胱氨酸转运蛋白胱氨酸的CTNS基因突变引起的,该突变导致氨基酸胱氨酸在体内的溶酶体内积聚,特别是影响肾脏。该病的早期表现包括肾性范可尼综合征,一种普遍的近端肾小管功能障碍。胱氨酸病的当前治疗方法是基于降低胱氨酸的药物胱胺,该药物可延缓疾病的进展,但无法治愈范可尼综合征。我们研究了在缺乏胱氨酸的人近端肾小管上皮细胞(PTEC)中重吸收受损的机制,并通过光学和电子显微镜研究了缺乏胱氨酸的PTEC的溶酶体腔室。我们证明胱氨酸蛋白酶缺陷细胞具有异常形状和内溶酶体区室分布和内吞作用受损,多配体受体表面表达降低和溶酶体货物加工延迟。半胱胺处理可改善表面表达和溶酶体货物加工,但不会导致完全恢复,对溶酶体区室的异常形态没有影响。获得的结果提高了我们对胱氨酸病中近端肾小管功能障碍机制的理解,并表明蛋白质重吸收受损可以至少部分地由内体囊泡的异常运输来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号